Hyperfine receives FDA 510(k) clearance for world's first bedside MRI system

Hyperfine receives FDA 510(k) clearance for world's first bedside MRI system

by www.news-medical.net February 14, 2020 0 Comments

Patients caught in crossfire between giant hospital chain, large insurer The Hyperfine point-of-care device represents multiple innovations in MRI design, architecture and workflow; more than 100 patents have been issued or are currently pending. The system is highly portable and wheels directly to the patient's bedside, plugs into a standard electrical wall outlet, and is controlled via a wireless tablet such as an Apple iPad ® . The Hyperfine system was designed to address the limitations of current MRI systems in order to make MRI accessible anytime, anywhere, to any patient. "More than 40 years after its first use, MRI remains a marvel. Unfortunately, it also remains inaccessible. It's time that MRI made the jump to point of need just like X-ray and ultrasound have before it," said Dr. Khan Siddiqui, Hyperfine's Chief Medical Officer. "Going beyond that, nearly 90% of the world has no access to MRI at all. With the FDA's decision, we are now ready to rewrite the rules of MRI accessibility." In developing the system, Hyperfine performed thousands of brain scans including those within investigational partnerships at Yale New Haven University, Penn Medicine, Good Samaritan Hospital Long Island, New York Presbyterian Brooklyn Methodist Hospital, and Brown University, in addition to calling upon seminal work from the Martinos Center for Biomedical Imaging at Massachusetts General Hospital. The FDA clearance includes head imaging for patients 2 years of age and older. Source:



www.news-medical.net
www.news-medical.net

Author




Also in Industry News

New insights may guide design of light-sensitive proteins with desired properties
New insights may guide design of light-sensitive proteins with desired properties

by www.news-medical.net February 15, 2020 0 Comments

New insights may guide design of light-sensitive proteins with desired properties

Read More

Scientists report promising activity of novel targeted drug in patients with advanced kidney cancer
Scientists report promising activity of novel targeted drug in patients with advanced kidney cancer

by www.news-medical.net February 15, 2020 0 Comments

Scientists report promising activity of novel targeted drug in patients with advanced kidney cancer

Read More

Study explains how certain mutations can shorten biological clock timing
Study explains how certain mutations can shorten biological clock timing

by www.news-medical.net February 15, 2020 0 Comments

Study explains how certain mutations can shorten biological clock timing

Read More